VivoSim Labs
VIVS
115 hedge funds and large institutions have $48.3M invested in VivoSim Labs in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 9 closing their positions.
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
6% more funds holding
Funds holding: 109 → 115 (+6)
0.01% more ownership
Funds ownership: 0.14% → 0.15% (+0.01%)
9% less capital invested
Capital invested by funds: $53.3M → $48.3M (-$4.99M)
73% less call options, than puts
Call options by funds: $36K | Put options by funds: $131K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.87M |
| 2 |
Renaissance Technologies
New York
|
+$396K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$197K |
| 4 |
BlackRock
New York
|
+$128K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$293K |
| 2 |
ALIONA
Allianz Life Insurance of North America
Minneapolis,
Minnesota
|
-$203K |
| 3 |
Morgan Stanley
New York
|
-$51.4K |
| 4 |
JG
Jefferies Group
New York
|
-$40K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$37K |
VIVS Hedge Fund Activity: Q3 2018 in Review
115 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2018, worth a combined $48.3M — down 9.4% from $53.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new VIVS positions and 9 closed out — a net gain of 6 holders — while 33 added to existing stakes and 21 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $3.87M. The largest seller was Charles Schwab, cutting an estimated $293K.
- 115 institutional investors held VivoSim Labs (VIVS) as of Q3 2018, up from 109 in Q2 2018.
- Funds reported $48.3M of VivoSim Labs stock for Q3 2018, down 9.4% quarter-over-quarter.
- 15 funds opened new VivoSim Labs positions in Q3 2018 and 9 closed out, a net change of +6 holders.
- The largest VivoSim Labs buyer in Q3 2018 was ARK Investment Management, an estimated $3.87M added.
- The largest VivoSim Labs seller in Q3 2018 was Charles Schwab, an estimated $293K sold.
Based on aggregated 13F filings for Q3 2018.